Patents
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
07/2006
07/26/2006EP1683793A1 Reaction product of resorcin and methyl ethyl ketone
07/26/2006EP1683792A1 Benzopyrone compounds, preparation method and use thereof
07/26/2006EP1683056A2 Method for identifying inhibitors using a homology model of polo-like kinase 1
07/26/2006EP1682552A1 Tocopherol-modified therapeutic drug compounds
07/26/2006EP0902003B1 Novel tetralone or benzopyranone derivatives and process for producing the same
07/26/2006CN1809552A Cannabinoid derivatives, methods of making, and use thereof
07/26/2006CN1809551A Flavanone compound and uses thereof
07/26/2006CN1807422A Reaction product of resorcin and methyl ethyl ketone
07/26/2006CN1266145C Synthesis of cannabinoids
07/26/2006CN1266144C Compound of flavonoid as well as application and dosage form of extract product of the compound
07/26/2006CN1265807C Flavonoid extract product containing pedaliin and application
07/25/2006US7081475 Wortmannin analogs and their use in inhibiting inhibiting PI-3-kinase activity in mammals as well as tumor formation in a subject are described herein as anticancer agents
07/25/2006US7081458 Small molecule, non-peptide antagonists; antidiabetic agents; obesity; {5-[1-4-Methoxy-2,3-dimethyl-phenyl)-ethyl]-(1S,4S)-2,5-diaza-bicyclo[2.2.1]hept-2-yl}-(4-trifluoromethyl-phenyl)-methanone
07/25/2006CA2159192C Immunomodulator cell adhesion inhibitor, and agent for treating and preventing autoimmune diseases
07/20/2006WO2006074501A1 Peptidic compounds
07/20/2006WO2006018310A3 Process for the working-up of a vitamin e- and vitamin e-acetate and rectification colum suitable therefore
07/20/2006US20060161009 Phase change ink formulations, colorant formulations, and methods of forming colorants
07/20/2006US20060160889 4-benzyl-2-phenylchroman skeleton with hydroxyl substitutions compounds; estrogen beta -receptors (ER beta ) modulator; hormone replacement therapy; osteoporosis, postmenopause; side effect reduction
07/20/2006US20060160882 Indoline derivatives
07/20/2006US20060160086 Method for continuous detection of an analyte, trifunctional detecting reagent used and detecting device
07/20/2006US20060160068 Fluorescent phosphophenol ligand analog of a reporter moleculeof a borapolyazaindacene, a coumarin, a xanthene, a cyanine, a fluorescent protein, or a phosphorescent dye covalently bonded through a linker
07/20/2006US20060159785 Grinding seeds to fine powder without precooling; defatting in hydrocarbon solvent (hexane or petroleum ether); extraction with medium polarity solvent (acetone) at 18 to 56 degrees C; evaporation of solvent; drying; and washing and drying crystalline silymarin extract.
07/20/2006CA2594411A1 Peptidic biaryl antibacterial compounds comprising one or more basic amino acids
07/19/2006EP1681289A1 Plant-origin beta3-adrenoceptor agonist and use of the same
07/19/2006EP1680412A1 Tocopheryl polyethylene glycol succinate articles and process for preparing tpgs articles
07/19/2006EP1680392A1 Process for the preparation of 2,3,5-trimethylhydroquinone diacylates
07/19/2006CN1803801A Method for preparing ellagic acid by pomegranate rind
07/19/2006CN1803800A Method for preparing 5-bromine-6-fluoro-8-methyl-1-ethyl-1,3,4,9- tetrahydropyrane[3,4-e] indole-1-ethyl acetate
07/19/2006CN1803790A Method for extracting apple polyphenol from apple pomace by supercritical CO2
07/19/2006CN1803789A Method for extracting glycyrrhizicacid, licorice flavone and licorice polysaccharide
07/19/2006CN1803788A Polymethoxylated flavone derivative with anticancer activity, its pharmaceutical composition, preparation method and application
07/19/2006CN1803787A Hypericum perforatum L. total flavone extracts, its preparation and application
07/19/2006CN1264839C Non-nucleoside reverse transcriptase inhibitors
07/19/2006CN1264499C Cosmtics treatment using novel retinoid
07/18/2006US7078386 Enhancing agent for nerve growth factor production comprising a compound having a coumarin backbone or a compound having a 2-dimethyl chroman backbone
07/18/2006CA2309771C New substitute dimeric derivatives, their preparation process and the pharmaceutical compositions that contain them
07/13/2006WO2006073563A2 Fluorescent affinity tag to enhance phosphoprotein detection
07/13/2006WO2006072748A1 Photochromic intraocular lens
07/13/2006WO2004010842A3 Lipophilic electrophoretic probes
07/13/2006US20060155135 Ink jet printing, reacting benzylamine-aldehyde compound with stearyl cyanoacetamide
07/13/2006US20060154988 intracellular inhibition of bacterial polypeptide deformylase in gramnegative bacteria,
07/13/2006US20060154253 Method for the validated construction of arrays
07/13/2006US20060153936 soybean saponin and/or malonyl isoflavone glycoside; a food or drink, a medicine, a cosmetic, an oral preparation, a dentifrice, an aromatic agent, a deodorant, detergent
07/13/2006DE10209139B4 Tricyclische Verbindungen Tricyclic Compounds
07/13/2006CA2593143A1 Photochromic intraocular lens
07/12/2006EP1678157A2 Heterocyclic compounds and methods of making and using thereof
07/12/2006EP1678130A2 Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromium-6-yl-derivatives and drugs containing said compounds
07/12/2006EP1394156B1 Chromene compound
07/12/2006EP1325748B1 Cyanidin mixture for the treatment of large intestine cancer
07/12/2006CN1800173A Preparation of vitamin E linolenin and vitamin E oleate
07/12/2006CN1800172A Kudzuvine flower isoflavone , monomer tectoridin and tectorigenin extraction method and uses
07/12/2006CN1800171A Podocarpus extract and its preparation method
07/12/2006CN1264153C 光记录介质 The optical recording medium
07/12/2006CN1263847C Sakuranetin biosynthesis and uses
07/12/2006CN1263762C Desugar and deaminosugar FR-008 derived polyketone antibiotics
07/12/2006CN1263743C Therapeutic morpholino-substituted compounds
07/12/2006CN1263728C Oxyalkylene-substituted aminophenol intermediate
07/11/2006US7074943 an oxygen-containing heterocyclic group F annelated on the i, j, or k side of the naphthopyran ring, having certain substituents at the 2, 5, and 6 positions of the naphthopyran ring; for ophthalmic lenses or other plastic transparencies that incorporate the naphthopyran compounds
07/11/2006US7074933 quinolin-2-ones and chromen-2-ones compounds that have been derivatized at the 6-position with a urea or thiourea derivative; used as androgen antagonists; kits
07/11/2006US7074823 Zinc complex containing spiro(phthalan-1,9'-xanthene) ring; measuring intensity of fluorescence
07/11/2006US7074819 Benzopyran or thiobenzopyran derivatives
07/11/2006US7074816 Gout; xanthine oxidase inhibitors; reacting iminoether or an aromatic nitrile with hydrazide
07/11/2006US7074420 Cosmetic treatment using a new retinoid
07/11/2006CA2262566C Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect
07/11/2006CA2125824C Heteroaryl coumarins as inhibitors of leukotriene biosynthesis
07/06/2006WO2006070984A1 Novel benzopyran derivatives having inhibitory activities against liver fibrosis and cirrhosis and their pharmaceutical uses
07/06/2006WO2006070810A1 Antioxidant material, anti-deterioration agent and food or beverage
07/06/2006WO2006069533A1 Desmosdumotins, their manufactures and use as antitumor and anti-aids agent
07/06/2006US20060148834 Novel coumarin-amide derivatives and its preparation, said drug composition and its use
07/06/2006US20060148724 Genipin derivatives and uses thereof
07/05/2006EP1675844A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
07/05/2006EP1675843A1 (3r, 4r) -trans-3,4-diarylchroman derivatives with estrogenic activity
07/05/2006EP1313739B1 Alkylated imidazopyridine derivatives
07/05/2006CN1798790A Ultra-ramified polycarbonates and copolycoarbonates exhibiting an improved flow characteristics, the production and use thereof.
07/05/2006CN1796381A Compound for treating B type hepatitis and medication composition
07/05/2006CN1796380A Antibacterial compound A-28, and application in preparing antibacterial drug
07/05/2006CN1796351A Method for preparing desmosdumotin, and application of anti tumour and AIDS
07/05/2006CN1262540C Bicycle androgen and progesterone receptor modulator compounds and methods
07/05/2006CN1262273C Chinese rose extract and its preparing method and use
07/04/2006US7071341 α-Glucosidase inhibitors and their synthesis from a natural source
07/04/2006US7071214 Compounds and compositions for delivering active agents
07/04/2006US7071179 Method of locking 1α-OH of vitamin D compounds in axial orientation
06/2006
06/29/2006WO2006068212A1 Lipase inhibitor and preventive/remedy for skin diseases
06/29/2006WO2006066863A1 Asymmetric hydrogenation of alkennes using chiral iridium complexes
06/29/2006WO2006066756A1 Chroman derivatives and uses thereof in the treatment of cns disorders
06/29/2006WO2006066746A1 Chroman derivatives and their use as 5-ht receptor ligands
06/29/2006WO2006018256A3 Process for the rectification of mixtures of high-boiling air-and/or temperature-sensitive useful products
06/29/2006US20060142594 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
06/29/2006US20060142211 Chromones and chromone derivatives and uses thereof
06/29/2006US20060141591 Method for producing optically active chroman-carboxylate
06/29/2006US20060137207 Flavonoid compounds as therapeutic antioxidants
06/29/2006DE19508608B4 Lichtbeständiges kosmetisches Mittel enthaltend Tetraalkylquercetin sowie Tetraalkylquercetine als solche Light stable cosmetic composition containing tetraalkylquercetin and Tetraalkylquercetine as such
06/29/2006DE112004001149T5 Herstellung von Tocopherolen unter Verwendung eines Wismutkatalysators Production of tocopherols using a bismuth catalyst
06/29/2006CA2592001A1 Chroman derivatives and their use as 5-ht receptor ligands
06/29/2006CA2591871A1 Target physiological function inactivator using photosensitizer-labeled fluorescent protein
06/29/2006CA2591810A1 Chroman derivatives and uses thereof in the treatment of cns disorders
06/28/2006EP1674484A2 Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid componds
06/28/2006EP1674460A1 Chromene compound
06/28/2006EP1673363A1 Method for producing 1-hydroperoxy-16-oxabicyclo [10.4.0]hexadecane
06/28/2006EP1673362A2 Method for producing chromane derivatives that are devoid of enantiomers and are substituted in position 2